ABCA1 and cancer: Cholesterol and its isoprenoid precursor IPP are endogenous substrates of ABCA1, and IPP efflux via ABCA1 is the driver of Vγ9Vδ2 T-lymphocyte-mediated immuno-killing of cancer cells [9–11].